Project Details
| Short title | Axis Trial: Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer. |
|---|---|
| Status | Finished |
| Effective start/end date | 1/12/08 → 31/12/17 |
Funding
- Queen Elizabeth Hospital Birmingham
Axis Trial: Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer.
- Porfiri, Emilio (Principal Investigator)